Research ArticleBRAIN
MR Imaging Correlates of Survival in Patients with High-Grade Gliomas
Whitney B. Pope, James Sayre, Alla Perlina, J. Pablo Villablanca, Paul S. Mischel and Timothy F. Cloughesy
American Journal of Neuroradiology November 2005, 26 (10) 2466-2474;
Whitney B. Pope
James Sayre
Alla Perlina
J. Pablo Villablanca
Paul S. Mischel

References
- 1.↵Mischel PS, Shai R, Shi T, et al. Identification of molecular subtypes of glioblastoma by gene expression profiling. Oncogene 2003;22:2361–2373
- 2.Burger PC, Heinz ER, Shibata T, Kleihues P. Topographic anatomy and CT correlations in the untreated glioblastoma multiforme. J Neurosurg 1988;68:698–704
- 3.↵Rees JH, Smirniotopoulos JG, Jones RV, Wong K. Glioblastoma multiforme: radiologic-pathologic correlation. Radiographics 1996;16:1413–1438; quiz 1462–1463
- 4.↵Kowalczuk A, Macdonald RL, Amidei C, et al. Quantitative imaging study of extent of surgical resection and prognosis of malignant astrocytomas. Neurosurgery 1997;41:1028–1036; discussion 1036–1038
- 5.↵Pierallini A, Bonamini M, Pantano P, et al. Radiological assessment of necrosis in glioblastoma: variability and prognostic value. Neuroradiology 1998;40:150–153
- 6.↵
- 7.↵Lacroix M, Abi-Said D, Fourney DR, et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 2001;95:190–198
- 8.↵Maldaun MV, Suki D, Lang FF, et al. Cystic glioblastoma multiforme: survival outcomes in 22 cases. J Neurosurg 2004;100:61–67
- 9.↵Laws ER, Parney IF, Huang W, et al. Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project. J Neurosurg 2003;99:467–473
- 10.Keles GE, Anderson B, Berger MS. The effect of extent of resection on time to tumor progression and survival in patients with glioblastoma multiforme of the cerebral hemisphere. Surg Neurol 1999;52:371–379
- 11.↵Stark AM, Nabavi A, Mehdorn HM, Blomer, U. Glioblastoma multiforme: report of 267 cases treated at a single institution. Surg Neurol 2005;63:162–169
- 12.↵
- 13.↵Breiman L, Friedman JH, Olshen RA, Stone CJ. Classification and regression trees. Belmont, CA: Wadsworth International Group;1984
- 14.↵Knopp EA, Cha S, Johnson G, et al. Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. Radiology 1999;211:791–798
- 15.↵Batchelor TT, Betensky RA, Esposito JM, et al. Age-dependent prognostic effects of genetic alterations in glioblastoma. Clin Cancer Res 2004;10:228–233
- 16.↵Donahue B, Scott CB, Nelson JS, et al. Influence of an oligodendroglial component on the survival of patients with anaplastic astrocytomas: a report of Radiation Therapy Oncology Group 83-02. Int J Radiant Oncol Biol Phys 1997;38:911–914
- 17.↵Kyritsis AP, Bondy ML, Xiao M, et al. Germline p53 gene mutations in subsets of glioma patients. J Natl Cancer Inst Mar 21994;86:344–349
- 18.↵Burger PC, Green SB. Patient age, histologic features, and length of survival in patients with glioblastoma multiforme. Cancer 1987;59:1617–1625
- 19.↵Raza SM, Fuller GN, Rhee CH, et al. Identification of necrosis-associated genes in glioblastoma by cDNA microarray analysis. Clin Cancer Res 2004;10:212–221
- 20.↵Sallinen PK, Sallinen SL, Helen PT, et al. Grading of diffusely infiltrating astrocytomas by quantitative histopathology, cell proliferation and image cytometric DNA analysis: comparison of 133 tumours in the context of the WHO 1979 and WHO 1993 grading schemes. Neuropathol Appl Neurobiol 2000;26:319–331
- 21.↵Jackson RJ, Fuller GN, Abi-Said D, et al. Limitations of stereotactic biopsy in the initial management of gliomas. Neurooncol 2001;3:193–200
- 22.↵Tortosa A, Vinolas N, Villa S, et al. Prognostic implication of clinical, radiologic, and pathologic features in patients with anaplastic gliomas. Cancer 2003;97:1063–1071
- 23.↵Law M, Yang S, Wang H, et al. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol 2003;24:1989–1998
- 24.↵Pronin IN, Holodny AI, Petraikin AV. MRI of high-grade glial tumors: correlation between the degree of contrast enhancement and the volume of surrounding edema. Neuroradiology 1997;39:348–350
- 24.↵Megyesi JF, Kachur E, Lee DH, et al. Imaging correlates of molecular signatures in oligodendrogliomas. Clin Cancer Res 2004;10:4303–4306
- 26.↵Hobbs SK, Shi G, Homer R, et al. Magnetic resonance image-guided proteomics of human glioblastoma multiforme. J Magn Reson Imaging 2003;18:530–536
In this issue
Advertisement
Whitney B. Pope, James Sayre, Alla Perlina, J. Pablo Villablanca, Paul S. Mischel, Timothy F. Cloughesy
MR Imaging Correlates of Survival in Patients with High-Grade Gliomas
American Journal of Neuroradiology Nov 2005, 26 (10) 2466-2474;
0 Responses
Jump to section
Related Articles
- No related articles found.
Cited By...
- Association of Graph-based Spatial Features with Overall Survival Status of Glioblastoma Patients
- MGMT Promoter Methylation Status in Initial and Recurrent Glioblastoma: Correlation Study with DWI and DSC PWI Features
- Assessment of Prognostic Value of Cystic Features in Glioblastoma Relative to Sex and Treatment with Standard-of-Care
- Deep Transfer Learning and Radiomics Feature Prediction of Survival of Patients with High-Grade Gliomas
- Prognostic value of magnetic resonance imaging features in low-grade gliomas
- Non-Contrast-Enhancing Tumor: A New Frontier in Glioblastoma Research
- Predicting cancer outcomes from histology and genomics using convolutional networks
- Prognostic Implications of Gadolinium Enhancement of Skull Base Chordomas
- Predicting cancer outcomes from histology and genomics using convolutional networks
- MR Imaging Characteristics Associate with Tumor-Associated Macrophages in Glioblastoma and Provide an Improved Signature for Survival Prognostication
- Radiomics in Brain Tumor: Image Assessment, Quantitative Feature Descriptors, and Machine-Learning Approaches
- T2-FLAIR Mismatch, an Imaging Biomarker for IDH and 1p/19q Status in Lower-grade Gliomas: A TCGA/TCIA Project
- The Initial Area Under the Curve Derived from Dynamic Contrast-Enhanced MRI Improves Prognosis Prediction in Glioblastoma with Unmethylated MGMT Promoter
- Early-Stage Glioblastomas: MR Imaging-Based Classification and Imaging Evidence of Progressive Growth
- Radiologic Features and Expression of Vascular Endothelial Growth Factor Stratify Survival Outcomes in Patients with Glioblastoma
- The Added Prognostic Value of Preoperative Dynamic Contrast-Enhanced MRI Histogram Analysis in Patients with Glioblastoma: Analysis of Overall and Progression-Free Survival
- Patterns of Tumor Contrast Enhancement Predict the Prognosis of Anaplastic Gliomas with IDH1 Mutation
- Quantification of Nonenhancing Tumor Burden in Gliomas Using Effective T2 Maps Derived from Dual-Echo Turbo Spin-Echo MRI
- MRI Grading versus Histology: Predicting Survival of World Health Organization Grade II-IV Astrocytomas
- Advanced Magnetic Resonance Imaging of the Physical Processes in Human Glioblastoma
- Extent of Resection of Glioblastoma Revisited: Personalized Survival Modeling Facilitates More Accurate Survival Prediction and Supports a Maximum-Safe-Resection Approach to Surgery
- Arterial Spin-Labeling Assessment of Normalized Vascular Intratumoral Signal Intensity as a Predictor of Histologic Grade of Astrocytic Neoplasms
- Relationship between Tumor Enhancement, Edema, IDH1 Mutational Status, MGMT Promoter Methylation, and Survival in Glioblastoma
- Survival Analysis of Patients with High-Grade Gliomas Based on Data Mining of Imaging Variables
- Conventional MRI evaluation of gliomas
- Evidence for Sequenced Molecular Evolution of IDH1 Mutant Glioblastoma From a Distinct Cell of Origin
- Relationship between radiological characteristics and combined 1p and 19q deletion in World Health Organization grade III oligodendroglial tumours
- Identification of noninvasive imaging surrogates for brain tumor gene-expression modules
- Relationship between Survival and Edema in Malignant Gliomas: Role of Vascular Endothelial Growth Factor and Neuronal Pentraxin 2
- MRI in patients with high-grade gliomas treated with bevacizumab and chemotherapy
This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.
More in this TOC Section
Similar Articles
Advertisement